AMPE — Ampio Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Ampio: Jumps after starting trial testing lead drug against COVID-19
Ampio Pharma: Rises on approval to test experimental drug in COVID-19
Brief: Ampio To Start First Clinical Trial In COVID-19 Program
Brief: Ampio Provides Update On COVID-19 Program
Brief: Ampio Reports Acceptance Of Publication On Potential Benefits Of Nebulized Ampion For Covid-19 Patients
Brief: Ampio Pharmaceuticals Files For Mixed Shelf Of Up To $100 Mln – SEC Filing
Brief: Ampio Suspends Patient Enrollment In Its Phase 3 Study Of Ampion
AMEX RESUMED AMPIO PHARMA
Brief: Ampio Pharma Says Based On Assessment, Management Has Raised Concerns About Ability To Continue As A Going Concern
Brief: Ampio Pharmaceuticals May Issue And Sell Shares Of Common Stock Having Aggregate Offering Price Of Up To $50 Mln
Brief: Ampio Pharmaceuticals Inc - More Than 350 Patients Have Now Reached AP-013 Study's 12-Week Primary Endpoint
Brief: Ampio Provides Update On late-stage trial Manufacturing for AP-013
Brief: Ampio Pharmaceuticals Updates Progress Of SpA Clinical Trial
Brief: Ampio Appoints Dan Stokely As The Company's New Chief Financial Officer
Brief: Empery Asset Management LP Reports 8.84% Passive Stake In Ampio Pharmaceuticals As Of June
Ampio Pharma: Drops after pricing deep-discounted stock deal
Brief: Ampio Pharmaceuticals Announces Pricing Of Public Offering
Ampio Pharma: Drops on planned stock offering
Brief: Ampio Pharmaceuticals Announces Proposed Public Offering Of Common Stock